Non-small Cell Lung Cancer
📧 Sign up to get email alerts when something new happens for Non-small Cell Lung Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: AZD0530 to Treat Recurrent Stage IIIB/IV NSCLC Previously Treated With Combination Chemotherapy [Phase 2]
Phase 2 trial update for AZD0530 in recurrent stage IIIB/IV non-small cell lung cancer previously treated with chemotherapy; status complete…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: Trial of RAD001 in Patients With Operable Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
Phase 1 clinical trial update of RAD001 (everolimus) in patients with operable non-small cell lung cancer has completed and results were pos…
-
CLINICAL_TRIALS trial_result · 2015-07-14Clinical Trial Update: TaxoteRe Plus Cisplatin Versus AlImta Plus Cisplatin in 1st Line Non-squamous Cell Type Lung Cancer [Phase 3]
A Phase 3 trial comparing TaxoteRe plus cisplatin versus AlImta plus cisplatin in first-line non-squamous non-small cell lung cancer was ter…
-
FDA approval · 2015-07-13FDA Approved: IRESSA — Original Application (AstraZeneca Pharmaceuticals LP)
This record documents the original FDA approval of IRESSA (gefitinib) by AstraZeneca for non-small cell lung cancer.
-
CLINICAL_TRIALS withdrawal · 2015-07-13Clinical Trial Update: Pemetrexed Disodium and Carboplatin or Cisplatin With or Without Erlotinib Hydrochloride in Treating Patient With Stage IV Non-Small Cell Lung Cancer Resistant to First-Line Therapy With Erlotinib Hydrochloride or Gefitinib [Phase 2]
A Phase 2 trial evaluating pemetrexed disodium with carboplatin or cisplatin, with or without erlotinib, for stage IV non-small cell lung ca…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2015-07-10Clinical Trial Update: Biofeedback Training in Patients With Advanced Lung Cancer - A Pilot Study [NA]
This document reports the termination of a pilot clinical trial evaluating biofeedback training in patients with advanced non-small cell lun…
-
CLINICAL_TRIALS withdrawal · 2015-07-08Clinical Trial Update: T790M Mutation Positive 2nd Line STandard of cAre Registry
ClinicalTrials.gov entry for a T790M mutation-positive, second-line standard of care registry in non-small cell lung cancer was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Evaluate Erlotinib Efficacy and Safety as the 2nd/3rd Treatment in NSCLC With EGFR M(-) and C-met(-) [Phase 2]
Clinical trial update evaluating erlotinib as second- or third-line therapy in non-small cell lung cancer patients with EGFR mutation-negati…
-
CLINICAL_TRIALS trial_result · 2015-07-03Clinical Trial Update: Study of Gleevec and Weekly Paclitaxel in Patients Aged 70 or Older With Advanced Non-small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluated imatinib (Gleevec) in combination with weekly paclitaxel in patients aged 70 and older with advanced non-small cel…
-
CLINICAL_TRIALS research · 2015-07-03Clinical Trial Update: Erlotinib 100mg qd Versus Gefitinib 250mg qd for EGFR Mutant Nsclc [Phase 2]
A Phase 2 trial comparing Erlotinib 100 mg daily to Gefitinib 250 mg daily in EGFR-mutant non-small cell lung cancer; the document provides …
-
CLINICAL_TRIALS trial_result · 2015-07-01Clinical Trial Update: Icotinib in Advanced Metastatic Patients With NSCLC Previously Treated With Chemotherapy [Phase 3]
A Phase 3 clinical trial evaluating icotinib in advanced/metastatic non-small cell lung cancer patients previously treated with chemotherapy…
-
CLINICAL_TRIALS trial_result · 2015-06-25Clinical Trial Update: Ridaforolimus With Cetuximab: Adv Non-Small Cell Lung, Colorectal, Head & Neck Cancer [Phase 1]
Phase 1 trial of ridaforolimus with cetuximab in non-small cell lung cancer is terminated; results posted.
-
CLINICAL_TRIALS research · 2015-06-25Clinical Trial Update: Comparison of Lobectomy and Segmentectomy for cT1aN0M0 Peripheral NSCLC [Phase 3]
A Phase 3 trial comparing lobectomy and segmentectomy for early-stage peripheral non-small cell lung cancer (cT1aN0M0); current status is un…
-
CLINICAL_TRIALS trial_result · 2015-06-24Clinical Trial Update: Safety Study of Imexon Plus Docetaxel in Lung, Breast or Prostate Cancer Patients [Phase 1]
Phase 1 safety study of Imexon plus Docetaxel in non-small cell lung cancer, breast cancer, and prostate cancer has completed.
-
CLINICAL_TRIALS withdrawal · 2015-06-24Clinical Trial Update: A Safety and Efficacy Trial of Amplimexon Plus Taxotere in Metastatic Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 safety and efficacy trial of Amplimexon in combination with Taxotere for metastatic non-small cell lung cancer was withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-06-16Clinical Trial Update: Proton Therapy With Chemotherapy for Stage III Non-Small Cell Lung Cancer (LU02) [NA]
Clinical trial update for proton therapy with chemotherapy in stage III non-small cell lung cancer; study terminated with results posted in …
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Safety and Effect of Pertuzumab in Patients With Advanced Non-Small Cell Lung Cancer, Which Has Progressed After Prior Chemotherapy [Phase 2]
Phase 2 study evaluating the safety and activity of pertuzumab in advanced non-small cell lung cancer after prior chemotherapy; the study ha…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Efficacy Study of Additional Chemotherapy After Concurrent Chemoradiation in Non-small Cell Lung Cancer [Phase 3]
Phase 3 clinical trial evaluating the efficacy of additional chemotherapy after concurrent chemoradiation in non-small cell lung cancer has …
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: A Study of LY2875358 in Japanese Participants With Advanced Cancer [Phase 1]
Phase 1 clinical trial of LY2875358 in Japanese participants with advanced cancer has completed, including non-small cell lung cancer and ly…
-
CLINICAL_TRIALS trial_result · 2015-06-08Clinical Trial Update: Phase I Trial of Docetaxel and Low-Dose Fractionated Radiation in the Treatment of Metastatic or Recurrent NSCLC [Phase 1]
Phase I trial evaluating docetaxel with low-dose fractionated radiation for metastatic or recurrent non-small cell lung cancer; the study ha…
-
CLINICAL_TRIALS withdrawal · 2015-06-08Clinical Trial Update: Sublingual Anvirzel in Advance Non-Small Cell Lung Cancer (NSCLC) [Phase 1]
A Phase 1 trial of sublingual Anvirzel for non-small cell lung cancer has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: Sorafenib and Erlotinib or Sorafenib Alone in Advanced Non-Small Cell Lung Cancer Progressing on Erlotinib [Phase 2]
A Phase 2 trial evaluating sorafenib with erlotinib or sorafenib alone in advanced non-small cell lung cancer progressing on erlotinib, with…
-
CLINICAL_TRIALS trial_result · 2015-06-02Clinical Trial Update: A Study of Tarceva (Erlotinib) in Patients With Locally Advanced or Metastatic Non-small Cell Lung Cancer Who Present EGFR Mutations [Phase 4]
Phase 4 study evaluating Tarceva (erlotinib) in patients with EGFR-mutant locally advanced or metastatic non-small cell lung cancer. Results…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Study of Docetaxel/Gemcitabine Followed by Chemo-radiotherapy (Chemo-RT), With or Without Consolidation Chemotherapy, in IIIA/IIIB Non Small Cell Lung Cancer (NSCLC) [Phase 2]
A phase II trial evaluating docetaxel/gemcitabine followed by chemoradiotherapy (with or without consolidation chemotherapy) for stage IIIA/…
-
CLINICAL_TRIALS trial_result · 2015-05-29Clinical Trial Update: Non-small Cell Lung Cancer and Quality of Life
A completed clinical trial focusing on non-small cell lung cancer and quality of life, sponsored by the University of Turku.